Lilly will pay the startup $45 million upfront for an RNA-based therapy in early development, and begin a research collaboration to unearth other, similar medicines.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,